8-K: ATI Physical Therapy Appoints Interim CFO Following Departure of Joseph Jordan
8-K Filing
ATI Physical Therapy, Inc. announces the appointment of Scott Rundell as Interim Chief Financial Officer, effective January 13, 2025, following the resignation of Joseph Jordan.
Summary
- Joseph Jordan resigned from his position as Chief Financial Officer of ATI Physical Therapy, Inc., effective January 10, 2025.
- Scott Rundell, the Vice President of Finance, has been appointed as the Interim Chief Financial Officer, effective January 13, 2025.
- Mr. Rundell has been with the company since March 2018, holding various finance positions.
- Mr. Rundell's compensation arrangements will not change, other than being eligible for a monthly bonus of $18,125 for up to four months.
- The Class A Common Stock was delisted from the New York Stock Exchange on December 3, 2024, and currently trades on the OTC Pink Sheets under the ticker ATIP.
- The NYSE filed a Form 25 to deregister the Common Stock, which will be effective on March 4, 2025.
- The warrants currently trade on the OTC Pink Sheets under the ticker ATIPW.
Sentiment
Score: 3
Explanation: The sentiment is negative due to the CFO's departure and the delisting from the NYSE, offset slightly by the quick appointment of an interim replacement.
Positives
- The company has quickly appointed an Interim CFO from within its existing finance team, ensuring continuity.
Negatives
- The departure of the CFO could indicate underlying issues within the company.
- The delisting of the Class A Common Stock from the NYSE is a negative development.
Risks
- The transition to a new CFO, even on an interim basis, could create uncertainty.
- Continued trading on the OTC Pink Sheets may limit investor access and liquidity.
Future Outlook
The document does not provide specific forward-looking statements beyond the appointment of the Interim CFO.
Industry Context
The appointment of an interim CFO is a common occurrence during periods of transition within a company. The delisting from the NYSE and subsequent trading on the OTC Pink Sheets suggests financial difficulties or non-compliance with listing requirements.
Comparison to Industry Standards
- It's difficult to compare this announcement to industry standards without knowing the specific reasons for the CFO's departure and the company's financial situation.
- Delisting from major exchanges is generally viewed negatively and can be compared to other companies that have faced similar situations, such as Sears or Toys 'R' Us, which ultimately led to bankruptcy.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | Joseph Jordan | Scott Rundell (Interim) | January 13, 2025 | Resignation of Joseph Jordan |
Stakeholder Impact
- Shareholders may be concerned about the CFO's departure and the delisting from the NYSE.
- Employees may experience uncertainty during the leadership transition.
Key Dates
| Date | Description |
|---|---|
| December 3, 2024 | Class A Common Stock delisted from the New York Stock Exchange |
| December 4, 2024 | NYSE filed a Form 25 to deregister the Common Stock |
| January 10, 2025 | Joseph Jordan's resignation as CFO became effective |
| January 13, 2025 | Scott Rundell appointed as Interim CFO |
| January 14, 2025 | Date of report |
| March 4, 2025 | Form 25 to deregister the Common Stock will be effective |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.